AIC proceedings - update
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Australian Clinical Labs Ltd has reached an agreement with the Australian Information Commissioner regarding a Privacy Act proceeding related to a cyberattack on Medlab Pathology. The agreement includes a proposed penalty payment and a contribution towards legal costs, pending Federal Court approval. ACL emphasizes that its own data and IT systems were not affected by the cyberattack and that there will be no significant impact on its operations or financial position beyond the settlement amount. This resolution allows ACL to focus on its strategic objectives and continue delivering high-quality pathology services.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Australian Clinical Labs Ltd on 6ix
Earlier from Australian Clinical Labs
- Appendix 4E and Financial Report 30 June 2025
- FY25 Results Announcement
- FY25 Results Presentation
- Response to ASX Aware Letter
- Appendix 4D and 1H25 financial statements
Later from Australian Clinical Labs
- On Market Share Buy Back
- ACL 1H26 financial results investor presentation
- Appendix 4D and 1H26 financial reports
- CEO contract update
- Class action proceedings
Follow Australian Clinical Labs into a list and get an email when it puts out news.
Follow Australian Clinical Labs